Skip to content

Inventiva S.A.

IVA· NasdaqCore metricsCIK 1756594

Pharmaceutical preparations552 peers

Close
Oct 29, 2026 · +0.54%
Market cap
$720.77M
193.24M shares
Filings
228
€4.45M
Q2 2025−47.4% FY24 yoy
-€175.88M
Q2 2025N/M FY24 yoy
-€62.94M
Q2 2025N/M FY24 yoy
—
—
—
-€1.62
Q2 2025N/M FY24 yoy
€122.08M
Q2 2025+258.7% FY24 yoy
$720.77M
—
—
—
—
—

Price

$3.7329.22%$1.54past year
Oct 29, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

€9.20MFY 2024
€17.48M0FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024
PeriodEndedValueKindSource trail
FY 20242024-12-31€9,198,000reported
FY 20232023-12-31€17,477,000reported
FY 20222022-12-31€12,179,000reported
FY 20212021-12-31€4,194,000reported
FY 20202020-12-31€372,000reported
FY 20192019-12-31€6,998,000reported
FY 20182018-12-31€3,197,000reported

Segments

Geography
Revenue by Geography, FY2020 to FY2022FY2020France · FY2020 · €372.00KFY2021France · FY2021 · €194.00KUSA · FY2021 · €4.00MFY2022China · FY2022 · €12.05MFrance · FY2022 · €125.00K
LineFY2022ShareChange
China€12.05M99%—
France€125.00K1.0%−35.6%
USA———
Total€12.18M

From the 20-F filed Mar 30, 2023IVA

Pharmaceutical preparations

Inventiva S.A. is the 177th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Inventiva S.A. · CIK 1756594 · Engraved from SEC EDGAR